Literature DB >> 20012654

Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells.

Yuki Nishimura-Sakurai1, Naoya Sakamoto, Kaoru Mogushi, Satoshi Nagaie, Mina Nakagawa, Yasuhiro Itsui, Megumi Tasaka-Fujita, Yuko Onuki-Karakama, Goki Suda, Kako Mishima, Machi Yamamoto, Mayumi Ueyama, Yusuke Funaoka, Takako Watanabe, Seishin Azuma, Yuko Sekine-Osajima, Sei Kakinuma, Kiichiro Tsuchiya, Nobuyuki Enomoto, Hiroshi Tanaka, Mamoru Watanabe.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) replication is affected by several host factors. Here, we screened host genes and molecular pathways that are involved in HCV replication by comprehensive analyses using two genotypes of HCV replicon-expressing cells, their cured cells and naïve Huh7 cells.
METHODS: Huh7 cell lines that stably expressed HCV genotype 1b or 2a replicon were used. The cured cells were established by treating HCV replicon cells with interferon-alpha. Expression of 54,675 cellular genes was analyzed by GeneChip DNA microarray. The data were analyzed by using the KEGG Pathway database.
RESULTS: Hierarchical clustering analysis showed that the gene-expression profiles of each cell group constituted clear clusters of naïve, HCV replicon-expressed, and cured cell lines. The pathway process analysis between the replicon-expressing and the cured cell lines identified significantly altered pathways, including MAPK, steroid biosynthesis and TGF-beta signaling pathways, suggesting that these pathways were affected directly by HCV replication. Comparison of cured and naïve Huh7 cells identified pathways, including steroid biosynthesis and sphingolipid metabolism, suggesting that these pathways were required for efficient HCV replication. Cytoplasmic lipid droplets were obviously increased in replicon-expressing and cured cells as compared to naïve cells. HCV replication was significantly suppressed by peroxisome proliferator-activated receptor (PPAR)-alpha agonists but augmented by PPAR-gamma agonists.
CONCLUSION: Comprehensive gene expression and pathway analyses show that lipid biosynthesis pathways are crucial to support proficient virus replication. These metabolic pathways could constitute novel antiviral targets against HCV.

Entities:  

Mesh:

Year:  2009        PMID: 20012654     DOI: 10.1007/s00535-009-0162-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  46 in total

1.  Expression of the hydrogen peroxide-generating enzyme fatty acyl CoA oxidase activates NF-kappaB.

Authors:  Y Li; J C Tharappel; S Cooper; M Glenn; H P Glauert; B T Spear
Journal:  DNA Cell Biol       Date:  2000-02       Impact factor: 3.311

2.  Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.

Authors:  Y Itsui; N Sakamoto; M Kurosaki; N Kanazawa; Y Tanabe; T Koyama; Y Takeda; M Nakagawa; S Kakinuma; Y Sekine; S Maekawa; N Enomoto; M Watanabe
Journal:  J Viral Hepat       Date:  2006-10       Impact factor: 3.728

3.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Authors:  Eileen Foy; Kui Li; Rhea Sumpter; Yueh-Ming Loo; Cynthia L Johnson; Chunfu Wang; Penny Mar Fish; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

4.  Negative regulation of intracellular hepatitis C virus replication by interferon regulatory factor 3.

Authors:  Tsuyoshi Yamashiro; Naoya Sakamoto; Masayuki Kurosaki; Nobuhiko Kanazawa; Yoko Tanabe; Mina Nakagawa; Cheng-Hsin Chen; Yasuhiro Itsui; Tomoyuki Koyama; Yoshie Takeda; Shinya Maekawa; Nobuyuki Enomoto; Hiroshi Sakugawa; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

5.  Suppression of hepatitis C virus replicon by TGF-beta.

Authors:  Takayuki Murata; Takayuki Ohshima; Masashi Yamaji; Masahiro Hosaka; Yusuke Miyanari; Makoto Hijikata; Kunitada Shimotohno
Journal:  Virology       Date:  2005-01-20       Impact factor: 3.616

6.  Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.

Authors:  Dana Schiefelbein; Oliver Seitz; Itamar Goren; Jan Philipp Dissmann; Helmut Schmidt; Malte Bachmann; Robert Sader; Gerd Geisslinger; Josef Pfeilschifter; Stefan Frank
Journal:  Mol Pharmacol       Date:  2008-07-03       Impact factor: 4.436

7.  Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

Authors:  Stephanos J Hadziyannis; Hoel Sette; Timothy R Morgan; Vijayan Balan; Moises Diago; Patrick Marcellin; Giuliano Ramadori; Henry Bodenheimer; David Bernstein; Mario Rizzetto; Stefan Zeuzem; Paul J Pockros; Amy Lin; Andrew M Ackrill
Journal:  Ann Intern Med       Date:  2004-03-02       Impact factor: 25.391

8.  Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production.

Authors:  Wei Yang; Brian L Hood; Sara L Chadwick; Shufeng Liu; Simon C Watkins; Guangxiang Luo; Thomas P Conrads; Tianyi Wang
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

9.  Proteomic approach identifies HSP27 as an interacting partner of the hepatitis C virus NS5A protein.

Authors:  Yook-Wah Choi; Yee-Joo Tan; Seng Gee Lim; Wanjin Hong; Phuay-Yee Goh
Journal:  Biochem Biophys Res Commun       Date:  2004-05-28       Impact factor: 3.575

10.  RNA quality in frozen breast cancer samples and the influence on gene expression analysis--a comparison of three evaluation methods using microcapillary electrophoresis traces.

Authors:  Carina Strand; Johan Enell; Ingrid Hedenfalk; Mårten Fernö
Journal:  BMC Mol Biol       Date:  2007-05-22       Impact factor: 2.946

View more
  19 in total

1.  Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91.

Authors:  Yusuke Funaoka; Naoya Sakamoto; Goki Suda; Yasuhiro Itsui; Mina Nakagawa; Sei Kakinuma; Takako Watanabe; Kako Mishima; Mayumi Ueyama; Izumi Onozuka; Sayuri Nitta; Akiko Kitazume; Kei Kiyohashi; Miyako Murakawa; Seishin Azuma; Kiichiro Tsuchiya; Mamoru Watanabe
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

Review 2.  The interaction between HCV and nuclear receptor-mediated pathways.

Authors:  Zoe Raglow; Carly Thoma-Perry; Richard Gilroy; Yu-Jui Yvonne Wan
Journal:  Pharmacol Ther       Date:  2011-05-18       Impact factor: 12.310

3.  Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus.

Authors:  Samantha Blackham; Andrew Baillie; Fadel Al-Hababi; Katja Remlinger; Shihyun You; Robert Hamatake; Michael J McGarvey
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

4.  Alteration of hepatic nuclear receptor-mediated signaling pathways in hepatitis C virus patients with and without a history of alcohol drinking.

Authors:  Chuanghong Wu; Richard Gilroy; Ryan Taylor; Mojtaba Olyaee; Bashar Abdulkarim; Jameson Forster; Maura O'Neil; Ivan Damjanov; Yu-Jui Yvonne Wan
Journal:  Hepatology       Date:  2011-12       Impact factor: 17.425

5.  Human placental mesenchymal stromal cell therapy restores the cytokine efflux and insulin signaling in the skeletal muscle of obesity-induced type 2 diabetes rat model.

Authors:  Nagasuryaprasad Kotikalapudi; Samuel Joshua Pragasam Sampath; Sukesh Narayan Sinha; R Bhonde; Sathish Kumar Mungamuri; Vijayalakshmi Venkatesan
Journal:  Hum Cell       Date:  2022-01-29       Impact factor: 4.174

6.  Psammaplin A inhibits hepatitis C virus NS3 helicase.

Authors:  Kazi Abdus Salam; Atsushi Furuta; Naohiro Noda; Satoshi Tsuneda; Yuji Sekiguchi; Atsuya Yamashita; Kohji Moriishi; Masamichi Nakakoshi; Masayoshi Tsubuki; Hidenori Tani; Junichi Tanaka; Nobuyoshi Akimitsu
Journal:  J Nat Med       Date:  2013-01-29       Impact factor: 2.343

Review 7.  Metabolic alterations and hepatitis C: From bench to bedside.

Authors:  Ming-Ling Chang
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

8.  Inhibition of hepatitis C virus replication by a specific inhibitor of serine-arginine-rich protein kinase.

Authors:  Yuko Karakama; Naoya Sakamoto; Yasuhiro Itsui; Mina Nakagawa; Megumi Tasaka-Fujita; Yuki Nishimura-Sakurai; Sei Kakinuma; Masaya Oooka; Seishin Azuma; Kiichiro Tsuchiya; Hiroshi Onogi; Masatoshi Hagiwara; Mamoru Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2010-05-24       Impact factor: 5.191

9.  Inhibition of both protease and helicase activities of hepatitis C virus NS3 by an ethyl acetate extract of marine sponge Amphimedon sp.

Authors:  Yuusuke Fujimoto; Kazi Abdus Salam; Atsushi Furuta; Yasuyoshi Matsuda; Osamu Fujita; Hidenori Tani; Masanori Ikeda; Nobuyuki Kato; Naoya Sakamoto; Shinya Maekawa; Nobuyuki Enomoto; Nicole J de Voogd; Masamichi Nakakoshi; Masayoshi Tsubuki; Yuji Sekiguchi; Satoshi Tsuneda; Nobuyoshi Akimitsu; Naohiro Noda; Atsuya Yamashita; Junichi Tanaka; Kohji Moriishi
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

10.  PPARs and HCV-Related Hepatocarcinoma: A Mitochondrial Point of View.

Authors:  Francesca Agriesti; Tiziana Tataranni; Vitalba Ruggieri; Nazzareno Capitanio; Claudia Piccoli
Journal:  PPAR Res       Date:  2012-08-16       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.